Study on the safe discontinuation method of entacapone/cordan

As an auxiliary method in the treatment of Parkinson's disease, Entacapone is usually used in combination with levodopa/benserazide or levodopa/carbidopa to improve symptom fluctuations and extend the duration of drug effect. Since the drug prolongs the action of levodopa by inhibiting catechol-O-methyltransferase (COMT), its discontinuation method requires scientific management to prevent sudden exacerbation of symptoms or the occurrence of "end-of-dose phenomenon."

Clinical practice shows that the core principles of safe drug withdrawal are Gradual dose reduction and close monitoring. It is generally recommended to reduce the daily dose in stages under the guidance of a doctor, and observe for 3-5 days after each dose reduction to evaluate the patient's motor function and non-motor symptoms, such as muscle stiffness, slow movement or worsening of tremor. For long-term users, sudden discontinuation of the drug may cause the plasma concentration of levodopa to drop too quickly, causing short-term symptom fluctuations and even increasing the risk of falls. Therefore, it is safer to gradually reduce the dose.

In addition, safe drug withdrawal must be combined with an individualized treatment strategy. For patients with cardiovascular disease or cognitive impairment, monitoring blood pressure, heart rate, and ability to perform daily activities is particularly important. During drug withdrawal, your doctor may adjust the dose of levodopa/carbidopa or benserazide to compensate for fluctuations in drug efficacy after discontinuation of entacapone. Overseas clinical guidelines also emphasize that patients should maintain a good lifestyle and regular exercise after stopping medication to assist in medication adjustment and reduce the risk of symptom rebound.

Generally speaking, the safe discontinuation method of entacapone emphasizes Step-by-step, dynamic monitoring and individualized management. Through reasonable dose reduction and combined adjustment with basic levodopa therapy, patients can avoid sudden symptoms and make a smooth transition, ensuring that daily life functions and exercise abilities are maintained at a relatively stable level